# Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial

> **NCT05132829** · PHASE4 · UNKNOWN · sponsor: **Thomas Jefferson University** · enrollment: 50 (estimated)

## Conditions studied

- Preterm Birth
- Obstetric Labor, Premature
- Obstetric Labor Complications
- Pregnancy Complications
- Physiological Effects of Drugs
- Uterine Cervical Incompetence
- Anti-Bacterial Agents
- Azithromycin
- Cefazolin

## Interventions

- **DRUG:** Azithromycin 1 gram IV
- **DRUG:** Cefazolin and indomethacin

## Key facts

- **NCT ID:** NCT05132829
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-20
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05132829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05132829, "Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05132829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*